Premium
Oral contraceptive exposure of amenorrheic women with and without prolactinomas
Author(s) -
Jones James R.,
Kemmann Ekkehard,
Norwood Paula K.
Publication year - 1981
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/0020-7292(81)90021-7
Subject(s) - medicine , gynecology , obstetrics
The purpose of this study was to determine the extent of oral contraceptive (OC) exposure of women with secondary amenorrhea of hypothalamic‐pituitary etiology. In 93 of 126 women with secondary amenorrhea sufficient data were obtained regarding menstrual history and OC exposure: 26 patients had evidence of a prolactinoma, an additional 26 patients had idiopathic hyperprolactinemia without evidence of a pituitary tumor, and 41 had “pure” dysfunction hypothalamicpituitary amenorrhea. After stratification by age at diagnosis and parity the estimated odds ratio for past oral contraceptive usage showed no differences among the three groups (odds ratios between 0.74 and 1.48). Using the chisquare test the proportion of subjects who had regular menses before oral contraceptive intake and developed anovulation immediately after discontinuance (“post pill amenorrhea”) in the three groups also showed no difference ( χ 2 = 0.60, P = 0.74). These data indicate that non‐ovulatory patients are likely to have been exposed to OC, and do not indicate that patients with prolactinomas differ in the extent of their OC exposure from other specified groups of patients with secondary amenorrhea.